Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-24 @ 7:47 PM
NCT ID:
NCT00571103
Eligibility Criteria:
Inclusion Criteria:
* Patients will meet DSM-IV (Diagnostic and Statistical Manual 4th Edition) criteria for Pathological Gambling Disorder
* Patients will achieve a SOGS (South Oaks Gambling Screen) score greater than or equal to 5
* Patients will be 18 years old or older
* Patients will speak standard English
* Patients will be able to give written Informed Consent
* Patients will be able to understand and cooperate with study procedures
Exclusion Criteria:
* Patients having a current (past 3 months) substance use disorder (except dependence)
* Patients having a Hamilton Depression Rating score of greater than or equal to 18 or a score on #1 (depressed mood) greater than 1.
* Patients having a clinically significant medical illness
* Patients at risk for aggressive or suicidal behavior
* Patients who have received the following interventions within the proscribed time prior to study entry: 1) a monoamine oxidase inhibitor within the previous 21 days; 2) long-acting phenothiazines within the previous 3 months; 3) other psychotropic drugs within the previous 14 days; 4) flu- oxetine within the previous 4 weeks.
* Patients having severe antisocial or borderline personality disorder
* Patients with a past or current diagnosis of schizophrenia, schizoaffective disorder, psychotic disorder, bipolar disorder, or delirium, dementia, or other clinically significant cognitive disorder.
* Patients initiating individual, group, or couple psychotherapy during the three moths prior to study entry (excluding Gambler's Anonymous)
* Patients having prior exposure to acamprosate
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00571103
Study Brief:
Protocol Section:
NCT00571103